FDA again warns Sun Pharma over Dadra facility

Regulatory NewsRegulatory NewsComplianceGenericsGMPManufacturingPharmaceuticalsQuality Assurance and ControlQuality management system/QMSRegulatory Intelligence/PolicyUnited StatesWarning letters